351 related articles for article (PubMed ID: 30553911)
1. Novel antibody against oligomeric amyloid-β: Insight into factors for effectively reducing the aggregation and cytotoxicity of amyloid-β aggregates.
Zhang X; Huai Y; Cai J; Song C; Zhang Y
Int Immunopharmacol; 2019 Feb; 67():176-185. PubMed ID: 30553911
[TBL] [Abstract][Full Text] [Related]
2. Functional Characteristics and Molecular Mechanism of a New scFv Antibody Against Aβ42 Oligomers and Immature Protofibrils.
Zhang Y; Sun Y; Huai Y; Zhang YJ
Mol Neurobiol; 2015 Dec; 52(3):1269-1281. PubMed ID: 25330935
[TBL] [Abstract][Full Text] [Related]
3. The protective effects and underlying mechanism of an anti-oligomeric Aβ42 single-chain variable fragment antibody.
Zhang Y; Chen X; Liu J; Zhang Y
Neuropharmacology; 2015 Dec; 99():387-95. PubMed ID: 26256421
[TBL] [Abstract][Full Text] [Related]
4. Dual Efficacy of a Catalytic Anti-Oligomeric Aβ42 scFv Antibody in Clearing Aβ42 Aggregates and Reducing Aβ Burden in the Brains of Alzheimer's Disease Mice.
Song C; Li H; Zheng C; Zhang T; Zhang Y
Mol Neurobiol; 2023 Oct; 60(10):5515-5532. PubMed ID: 37326904
[TBL] [Abstract][Full Text] [Related]
5. The Mode of Action of an Anti-Oligomeric Amyloid β-Protein Antibody Affects its Protective Efficacy.
Zhang Y; Huai Y; Zhang X; Song C; Cai J; Zhang Y
Neurotox Res; 2019 Feb; 35(2):304-317. PubMed ID: 30229545
[TBL] [Abstract][Full Text] [Related]
6. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
7. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
[TBL] [Abstract][Full Text] [Related]
8. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
[TBL] [Abstract][Full Text] [Related]
9. Synergetic effect of matrine on the catalytic scFv antibody HS72 in vitro and in mice with Alzheimer disease pathology.
Song C; Li H; Zhang T; Zheng C; Zhang Y
Neuropharmacology; 2024 Jan; 242():109775. PubMed ID: 37913984
[TBL] [Abstract][Full Text] [Related]
10. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear and mixed inhibitory effect of matrine on the cytotoxicity of oligomeric amyloid-β protein.
Yang B; Li H; Zhang T; Wang Z; Li H; Zhang Y
Neurochem Int; 2020 Jul; 137():104746. PubMed ID: 32325190
[TBL] [Abstract][Full Text] [Related]
13. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
[TBL] [Abstract][Full Text] [Related]
14. Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer's Disease Patients.
Sancesario GM; Nuccetelli M; Cerri A; Zegeer J; Severini C; Ciotti MT; Pieri M; Martorana A; Caltagirone C; Nistico R; Bernardini S
Curr Alzheimer Res; 2018; 15(7):628-636. PubMed ID: 29359669
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of Inter-Molecular Interactions Between Single Aβ
Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
[TBL] [Abstract][Full Text] [Related]
16. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
18. Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer's Disease Therapeutic Antibodies.
Fan X; Xu L; Zhang J; Wang Y; Wu Z; Sun W; Yao X; Wang X; Guan S; Shan Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176076
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Mono-Triazole Derivatives Inhibit Aβ
Kaur A; Narang SS; Kaur A; Mann S; Priyadarshi N; Goyal B; Singhal NK; Goyal D
Chem Res Toxicol; 2019 Sep; 32(9):1824-1839. PubMed ID: 31402645
[TBL] [Abstract][Full Text] [Related]
20. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
